The Biotech Brief brings you clear, concise updates on the most impactful developments in biotechnology, precision medicine, and life science innovation. Produced by The HEII (Hub for Empowering Impactful Initiatives), this podcast breaks down clinical trial wins, regulatory shifts, and emerging therapeutic strategies in a format designed for busy scientists, entrepreneurs, investors, and changemakers. If you’re new to following the industry, this podcast is also for you. Stay informed. Stay inspired. Stay briefed.
All content for The Biotech Brief is the property of The HEII and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
The Biotech Brief brings you clear, concise updates on the most impactful developments in biotechnology, precision medicine, and life science innovation. Produced by The HEII (Hub for Empowering Impactful Initiatives), this podcast breaks down clinical trial wins, regulatory shifts, and emerging therapeutic strategies in a format designed for busy scientists, entrepreneurs, investors, and changemakers. If you’re new to following the industry, this podcast is also for you. Stay informed. Stay inspired. Stay briefed.
3: Disappointing Data. Cosentyx Doesn’t Deliver in Giant Cell Arteritis
The Biotech Brief
5 minutes 2 seconds
3 months ago
3: Disappointing Data. Cosentyx Doesn’t Deliver in Giant Cell Arteritis
Novartis’ blockbuster Cosentyx has hit a wall. In this episode of The Biotech Brief, we unpack the Phase 3 GCAptAIN trial results, where Cosentyx failed to show benefit for patients with giant cell arteritis. We explore what GCA is, why this label expansion mattered, and how the drug—once seen as a contender in this space—fell short. Plus, we look at the commercial implications, the competitive IL-6 landscape, and what this means for the future of Cosentyx and Novartis’ inflammatory disease pipeline.
The Biotech Brief
The Biotech Brief brings you clear, concise updates on the most impactful developments in biotechnology, precision medicine, and life science innovation. Produced by The HEII (Hub for Empowering Impactful Initiatives), this podcast breaks down clinical trial wins, regulatory shifts, and emerging therapeutic strategies in a format designed for busy scientists, entrepreneurs, investors, and changemakers. If you’re new to following the industry, this podcast is also for you. Stay informed. Stay inspired. Stay briefed.
